Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-26-069843
Filing Date
2026-06-03
Accepted
2026-06-03 08:33:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 tm2616774d1_424b3.htm 424B3 7924
  Complete submission text file 0001104659-26-069843.txt   9069
Mailing Address 12611 HIDDENCREEK WAY UNIT C CERRITOS CA 90703
Business Address 12611 HIDDENCREEK WAY UNIT C CERRITOS CA 90703 213-273-5453
Liminatus Pharma, Inc. (Filer) CIK: 0001971387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-293364 | Film No.: 261059036
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)